Skip to main content

Table 2 Pooled analyses of the association between VDR rs7975232 polymorphism and susceptibility to psoriasis

From: Pooling analysis regarding the impact of human vitamin D receptor variants on the odds of psoriasis

Models

M

I2

P heterogeneity

Stratification

case/control (N)

OR [95% CI]

P association

BH

allele C vs. A

R

74.2%

< 0.001

overall

1654/1991 (13)

1.05 [0.85~1.30]

0.640

0.960

83.4%

< 0.001

Asian

1212/1153 (8)

0.980 [0.70~1.38]

0.921

0.921

6.4%

0.361

Caucasian

392/788 (4)

1.16 [0.96~1.39]

0.123

0.346

74.6%

< 0.001

PB

1312/1650 (12)

1.02 [0.81~1.30]

0.849

0.856

57.4%

0.071

China

888/790 (4)

1.26 [0.99~1.61]

0.065

0.195

75.8%

< 0.001

PHWE > 0.05

1604/1941 (12)

1.07 [0.85~1.33]

0.567

0.740

76.2%

< 0.001

PCR-RFLP

770/1041 (9)

0.93 [0.69~1.27]

0.668

0.819

CC vs. AA

R

55.6%

0.008

overall

1654/1991 (13)

1.11 [0.76~1.64]

0.585

0.960

71.9%

0.001

Asian

1212/1153 (8)

0.91 [0.48~1.71]

0.761

0.921

0.0%

0.653

Caucasian

392/788 (4)

1.31 [0.91~1.90]

0.147

0.346

55.7%

0.010

PB

1312/1650 (12)

1.04 [0.69~1.59]

0.838

0.856

72.6%

0.012

China

888/790 (4)

1.11 [0.76~1.64]

0.718

0.718

59.3%

0.005

PHWE > 0.05

1604/1941 (12)

1.11 [0.74~1.65]

0.617

0.740

60.5%

0.009

PCR-RFLP

770/1041 (9)

0.93 [0.52~1.66]

0.803

0.819

AC vs. AA

R

61.0%

0.002

overall

1654/1991 (13)

1.15 [0.85~1.54]

0.370

0.960

68.2%

0.003

Asian

1212/1153 (8)

1.10 [0.70~1.72]

0.683

0.921

45.9%

0.136

Caucasian

392/788 (4)

1.27 [0.84~1.91]

0.257

0.346

64.0%

0.001

PB

1312/1650 (12)

1.11 [0.78~1.57]

0.578

0.856

83.2%

< 0.001

China

888/790 (4)

1.15 [0.64~2.07]

0.638

0.718

60.6%

0.003

PHWE > 0.05

1604/1941 (12)

1.20 [0.89~1.63]

0.235

0.478

62.2%

0.007

PCR-RFLP

770/1041 (9)

0.94 [0.58~1.54]

0.819

0.819

AC + CC vs. AA

R

63.5%

0.001

overall

1654/1991 (13)

1.15 [0.86~1.54]

0.356

0.960

71.6%

0.001

Asian

1212/1153 (8)

1.06 [0.68~1.66]

0.800

0.921

43.5%

0.151

Caucasian

392/788 (4)

1.30 [0.89~1.90]

0.179

0.346

66.0%

0.001

PB

1312/1650 (12)

1.10 [0.78~1.55]

0.595

0.856

79.1%

0.002

China

888/790 (4)

1.24 [0.75~2.04]

0.402

0.603

63.6%

0.001

PHWE > 0.05

1604/1941 (12)

1.20 [0.89~1.62]

0.239

0.478

65.8%

0.003

PCR-RFLP

770/1041 (9)

0.93 [0.57~1.52]

0.771

0.819

CC vs. AA+AC

R

63.9%

0.001

overall

1654/1991 (13)

1.01 [0.74~1.39]

0.928

0.977

77.4%

< 0.001

Asian

1212/1153 (8)

0.91 [0.57~1.47]

0.712

0.921

0.0%

0.943

Caucasian

392/788 (4)

1.19 [0.86~1.64]

0.295

0.346

63.8%

0.001

PB

1312/1650 (12)

0.97 [0.69~1.35]

0.856

0.856

20.8%

0.286

China

888/790 (4)

1.26 [0.88~2.14]

0.205

0.410

66.7%

0.001

PHWE > 0.05

1604/1941 (12)

1.00 [0.72~1.39]

0.977

0.977

69.8%

0.001

PCR-RFLP

770/1041 (9)

0.93 [0.60~1.42]

0.727

0.819

carrier C vs. A

F

42.3%

0.053

overall

1654/1991 (13)

1.08 [0.96~1.21]

0.977

0.977

63.1%

0.008

Asian

1212/1153 (8)

1.08 [0.93~1.25]

0.313

0.921

0.0%

0.720

Caucasian

392/788 (4)

1.10 [0.90~1.34]

0.346

0.346

43.6%

0.053

PB

1312/1650 (12)

1.04 [0.92~1.19]

0.507

0.856

0.0%

0.578

China

888/790 (4)

1.23 [1.03~1.47]

0.020

0.120

45.9%

0.041

PHWE > 0.05

1604/1941 (12)

1.09 [0.96~1.22]

0.170

0.478

46.3%

0.061

PCR-RFLP

770/1041 (9)

0.96 [0.82~1.13]

0.650

0.819

  1. M statistical model, R random effect, F fixed effect, PHWE P-value of Hardy-Weinberg equilibrium, Pheterogeneity P-value of Cochrane’s Q statistic for the assessment of heterogeneity, N Number of included case-control studies, OR odds ratio, CI confidence interval, Passociation P-value of association
  2. BH Benjamini & Hochberg-adjusted Passociation